1 Reason to Buy the SpaceX IPO and 3 Reasons to Avoid It

SpaceX’s IPO is expected to price at $135 per share, with about 556 million shares set to raise roughly $75 billion and an estimated 30% potentially available to retail investors. The article argues the stock may see a first-day pop, with Hyperliquid futures implying about $155, but warns the company could be overvalued at $1.75 trillion and face significant volatility as lockups expire over the next six months. It also cites a weak IPO history: 1,724 public debuts from 2011-2024 posted a weighted-average first-year return of -1.7%.

Analysis

The immediate winner is not the issuer but the market plumbing around it. A mega-deal of this size tends to compress implied volatility across the IPO ecosystem for a short window, while boosting volume and fee pools for the listing venue, brokers, and index/prime intermediaries; NDAQ is a cleaner way to express that than trying to own the deal itself. If retail participation is unusually high, first-week trading may be dominated by momentum-chasing rather than fundamental buyers, which increases the odds of a sharp opening pop followed by a liquidity air pocket once flippers and hedgers unwind.

The second-order risk is supply overhang, not valuation alone. Staggered lockups can create a series of mini-overhang events over 2-6 months, and those dates often matter more than the headline IPO price because dealers hedge ahead of them, mechanically pressuring the stock before actual shares hit the tape. That dynamic also raises dispersion: the issuer may underperform even if the broader AI/space complex stays firm, because the stock becomes the natural source of supply for early holders looking to de-risk.

The contrarian read is that the market may be underestimating how quickly narrative can outrun fundamentals in a scarce-name, scarcity-premium IPO. If retail access is broad and the float is still tight after listing, a sustained squeeze is plausible in the first several sessions, especially if derivatives pricing stays elevated and creates feedback from hedging flows. But the more durable trade is usually the opposite of the opening-day excitement: wait for post-lockup pressure or a failed breakout before getting involved.

For the named tickers, NVDA and INTC are only modestly affected directly, but any capital market enthusiasm around orbital AI compute is a sentiment tailwind for NVDA and a strategic pressure point for INTC to keep talking up differentiated AI infrastructure. MORN benefits from the valuation debate and public-markets attention, while NFLX is basically a clean read-through to the broader “big IPOs are hard” cautionary tone rather than a fundamental link.

Key Decisions for Investors

• Go long NDAQ for 1-3 months as a higher-quality way to own the IPO cycle; use a 5-8% pullback as entry, with upside tied to record listing activity and trading volumes rather than single-name underwriting risk.
• If you want event-driven exposure, buy short-dated straddles or strangles on the IPO after the first two sessions, not on day one; target realized volatility around the first lockup/tranche dates where price swings can exceed implied by 2-3 turns.
• Fade the first-day pop via a disciplined short only after the opening range is established and borrow is accessible; risk/reward is better if the stock trades >15-20% above issue and then loses intraday momentum.
• Use NVDA as a relative winner if the market starts pricing orbital/AI compute optionality; pair long NVDA vs. short a high-duration, cash-intensive AI beneficiary that lacks infrastructure leverage, with a 3-6 month horizon.
• Avoid chasing MORN on the headline; if it rallies on IPO-fever sentiment, treat it as a trim/hedge candidate because the best outcome is higher transaction activity, not a sustained re-rating.